Does Rallies show Form 4 insider transactions for AHR?

Yes. Rallies tracks AHR insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is AHR research on Rallies investment advice?

No. Rallies provides research, data, and educational context for AHR. It does not provide personalized investment advice.

AHR (American Healthcare REIT, Inc.) Stock Analysis - Insider Trades

American Healthcare REIT, Inc. (AHR) is a publicly traded Real Estate sector company. As of May 21, 2026, AHR trades at $50.71 with a market cap of $9.65B and a P/E ratio of 122.04. AHR moved +1.71% today. Year to date, AHR is +10.64%; over the trailing twelve months it is +46.49%. Its 52-week range spans $23.66 to $54.67. Analyst consensus is strong buy with an average price target of $57.57. Rallies surfaces AHR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading AHR stock inside the company?

Recent AHR insider activity includes Foster Mark E. sold 2.00K, Hanson Jeffrey T sold 19.21K, Hanson Jeffrey T sold 35.57K, Foster Mark E. sold 1.50K, and Hanson Jeffrey T sold 20.01K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

AHR Key Metrics

Key financial metrics for AHR
Metric	Value
Price	$50.71
Market Cap	$9.65B
P/E Ratio	122.04
EPS	$0.42
Dividend Yield	0.25%
52-Week High	$54.67
52-Week Low	$23.66
Volume	113.71K
Avg Volume	0
Revenue (TTM)	$2.26B
Net Income	$70.82M
Gross Margin	20.64%

Recent AHR Insider Trades

Foster Mark E. sold 2.00K (~$97.10K) on Mar 25, 2026.
Hanson Jeffrey T sold 19.21K (~$929.69K) on Dec 23, 2025.
Hanson Jeffrey T sold 35.57K (~$1.72M) on Dec 22, 2025.
Foster Mark E. sold 1.50K (~$74.03K) on Nov 11, 2025.
Hanson Jeffrey T sold 20.01K (~$994.10K) on Nov 10, 2025.

Latest AHR News

American Healthcare REIT Q1 NFFO Up 30%, Same-Store NOI +12.1%, Raises 2026 Guidance — May 7, 2026
American Healthcare REIT Forecasts Q1 Revenue $662.3M, EPS $0.15; Raises 2026 Revenue — May 6, 2026
AHR jumps as REIT expands revolver to $800M and extends maturity to 2030 — Apr 23, 2026
American Healthcare REIT slides as $1.75B ATM equity program revives dilution worries — Apr 22, 2026
American Healthcare REIT drops as traders price in dilution risk from $1.75B ATM — Apr 13, 2026

AHR Analyst Consensus

9 analysts cover AHR: 0 strong buy, 8 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $57.57.

Common questions about AHR

Who is trading AHR stock inside the company?: Recent AHR insider activity includes Foster Mark E. sold 2.00K, Hanson Jeffrey T sold 19.21K, Hanson Jeffrey T sold 35.57K, Foster Mark E. sold 1.50K, and Hanson Jeffrey T sold 20.01K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for AHR?: Yes. Rallies tracks AHR insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is AHR research on Rallies investment advice?: No. Rallies provides research, data, and educational context for AHR. It does not provide personalized investment advice.